We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $4.85B
1-Year Est. Return 9.66%
This Fund
S&P 500
This Quarter Est. Return
-0.13%
1 Year Est. Return
+9.66%
3 Year Est. Return
+69.39%
5 Year Est. Return
+96.17%
10 Year Est. Return
+350.87%
AUM
$4.83B
AUM Growth
-$106M
Cap. Flow
-$25.6M
Cap. Flow %
-0.53%
Top 10 Hldgs %
48.55%
Holding
187
New
8
Increased
32
Reduced
83
Closed
8

Top Buys

Rank Stock Value
1
FTRE icon
Fortrea Holdings
FTRE
+$36.3M
2
FERG icon
Ferguson
FERG
+$27.2M
3
CSGP icon
CoStar Group
CSGP
+$11.5M
4
OWL icon
Blue Owl Capital
OWL
+$9.48M
5
CACC icon
Credit Acceptance
CACC
+$9.31M

Top Sells

Rank Stock Value
1
SHW icon
Sherwin-Williams
SHW
+$21.4M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$13.9M
3
MSFT icon
Microsoft
MSFT
+$13.9M
4
QCOM icon
Qualcomm
QCOM
+$10.7M
5
JEF icon
Jefferies Financial Group
JEF
+$9.81M

Sector Composition

Rank Sector Weight
1 Financials 40.82%
2 Healthcare 13.34%
3 Technology 13.15%
4 Communication Services 7.86%
5 Industrials 7.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CET
151
Central Securities Corp
CET
$1.54B
$248K 0.01%
5,645
+811
+17% +$34.2K
VB icon
152
Vanguard Small-Cap ETF
VB
$78.9B
$246K 0.01%
1,130
– –
MS icon
153
Morgan Stanley
MS
$319B
$243K 0.01%
2,500
– –
QQQ icon
154
Invesco QQQ Trust
QQQ
$436B
$240K 0.01%
500
– –
MRSH
155
Marsh
MRSH
$94.3B
$236K ﹤0.01%
1,120
– –
PCG icon
156
PG&E
PCG
$39B
$227K ﹤0.01%
+13,000
New +$229K
CB icon
157
Chubb
CB
$140B
$219K ﹤0.01%
+858
New +$220K
VRCA icon
158
Verrica Pharmaceuticals
VRCA
$89M
$219K ﹤0.01%
3,000
– –
KMI icon
159
Kinder Morgan
KMI
$70.9B
$216K ﹤0.01%
10,850
-2,842
-21% -$54.2K
AZN icon
160
AstraZeneca
AZN
$269B
$212K ﹤0.01%
+1,357
New +$204K
AMT icon
161
American Tower
AMT
$83.5B
$207K ﹤0.01%
1,063
– –
DXCM icon
162
DexCom
DXCM
$29B
$206K ﹤0.01%
1,818
– –
VTRS icon
163
Viatris
VTRS
$20.8B
$113K ﹤0.01%
10,667
– –
SJT
164
San Juan Basin Royalty Trust
SJT
$119M
$85.6K ﹤0.01%
21,080
-1,900
-8% -$8.35K
SENS icon
165
Senseonics Holdings Inc
SENS
$254M
$60.3K ﹤0.01%
7,560
+2,517
+50% +$22.4K
RIG icon
166
Transocean
RIG
$5.48B
$53.5K ﹤0.01%
10,000
– –
BB icon
167
BlackBerry
BB
$4.58B
$46.3K ﹤0.01%
18,650
-59,000
-76% -$164K
LUMN icon
168
Lumen
LUMN
$6.43B
$25.2K ﹤0.01%
22,923
– –
AMRN
169
Amarin Corp
AMRN
$297M
$20.6K ﹤0.01%
1,500
– –
AMP icon
170
Ameriprise Financial
AMP
$47.8B
– –
-539
Closed -$236K
BMY icon
171
Bristol-Myers Squibb
BMY
$129B
– –
-6,797
Closed -$369K
GEHC icon
172
GE HealthCare
GEHC
$32.7B
– –
-3,219
Closed -$293K
IEX icon
173
IDEX
IEX
$17B
– –
-2,250
Closed -$549K
VLTO icon
174
Veralto
VLTO
$24.3B
– –
-2,755
Closed -$244K
WBS icon
175
Webster Financial
WBS
$12.3B
– –
-4,091
Closed -$208K
4 5 6
7
8

Similar funds

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
MCCA
Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
JSTA
Japan Science & Technology Agency Tokyo, Japan $4.81B AUM 4.62% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return

Beck Mack & Oliver's Q2 2024 Portfolio in Review

As of Q2 2024, Beck Mack & Oliver held 187 positions worth $4.83B, down 2.1% from $4.93B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Beck Mack & Oliver's Q2 2024 filing shows 8 new, 32 increased, 83 reduced and 8 closed positions. Its largest new stake was Loar Holdings: 65,700 shares worth $3.51M. The largest sale was Sherwin-Williams, an estimated $21.4M.

By sector, the portfolio is most concentrated in Financials at 41% of assets, up from 41% a quarter earlier, followed by Healthcare and Technology.

  • Beck Mack & Oliver's largest Q2 2024 buy was Loar Holdings: 65,700 shares worth $3.51M.
  • Beck Mack & Oliver added most to Fortrea Holdings in Q2 2024, an estimated $36.3M increase.
  • Beck Mack & Oliver's biggest Q2 2024 reduction was Sherwin-Williams, cutting an estimated $21.4M.
  • Beck Mack & Oliver fully exited IDEX in Q2 2024, selling an estimated $549K.
  • Beck Mack & Oliver's ten largest holdings make up 49% of its $4.83B portfolio in Q2 2024.
  • Beck Mack & Oliver opened 8 new positions and closed 8 in Q2 2024.
  • Beck Mack & Oliver's portfolio value fell 2.1% quarter-over-quarter to $4.83B.

Based on Beck Mack & Oliver's 13F filing for Q2 2024, filed 14 Aug 2024.